Heartseed Management Team
4 Team Members
Heartseed has 4 executives. Heartseed's current Chief Financial Officer is Mutsuki TAKANO.
You May Also Like
Avery Therapeutics is a company that focuses on developing tissue-engineered therapeutics to treat diseases and injuries to human muscles. Its main product, MyCardia, is being developed to address and treat heart failure. It specializes in tissue engineering therapeutics, tissue engineering, regenerative medicine, cardiology, and more. It was founded in 2016 and is based in Tucson, Arizona.
CUORiPS is a developer of cell therapy products. The company develops allogeneic iPSC-derived cardiomyocyte sheets for the treatment of heart failure. It aims to enable transplantation of the sheets for patients with severe deficiencies in their heart function.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.